多瑞医药
(301075)
| 流通市值：4.99亿 | | | 总市值：14.55亿 |
| 流通股本：2742.37万 | | | 总股本：8000.00万 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 326,221,492.71 | 405,270,705.96 | 426,516,399.55 | 476,639,537.54 |
| 应收票据及应收账款 | 83,179,837.79 | 82,235,812.18 | 70,772,715.4 | 69,546,475.51 |
| 其中：应收票据 | 330,268 | 2,499,470.93 | - | - |
| 应收账款 | 82,849,569.79 | 79,736,341.25 | 70,772,715.4 | 69,546,475.51 |
| 应收款项融资 | 39,138 | 3,270,875.7 | - | - |
| 预付款项 | 30,673,639.99 | 26,686,990.33 | 48,782,971.52 | 31,108,419.59 |
| 其他应收款合计 | 13,652,811.94 | 11,197,973.18 | 11,958,705.5 | 9,263,263.21 |
| 存货 | 31,374,246.99 | 33,128,080.17 | 30,434,392.25 | 19,304,092.66 |
| 其他流动资产 | 10,166,049.03 | 9,592,593.37 | 8,345,646.59 | 1,088,874 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 682,373,216.45 | 648,948,030.89 | 676,810,830.81 | 666,950,662.51 |
| 非流动资产: | | | | |
| 长期股权投资 | 87,055,807.98 | 85,752,304.16 | 122,243,237.41 | 82,811,970.91 |
| 其他权益工具投资 | 78,795,388.23 | 69,605,388.23 | 37,605,540 | 48,415,540 |
| 固定资产 | 192,089,320.64 | 199,840,159.36 | 192,698,874.49 | 99,612,930.5 |
| 在建工程 | 16,740,365.5 | 9,081,577.9 | 7,180,141.47 | 4,022,379.36 |
| 使用权资产 | 733,204.51 | 879,845.42 | 879,845.4 | 1,173,127.22 |
| 无形资产 | 33,930,001.41 | 34,191,536.66 | 34,584,293.21 | 21,294,857.68 |
| 商誉 | 3,881,342.55 | 3,685,495.93 | 3,042,162.78 | - |
| 长期待摊费用 | 3,352,315.83 | 2,700,160.12 | 931,711.01 | 792,756.95 |
| 递延所得税资产 | 1,299,507.98 | 1,253,774.13 | 1,423,069.27 | 807,958.34 |
| 其他非流动资产 | 16,176,562 | 16,327,323.75 | 5,000,000 | 28,176,562 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 434,053,816.63 | 423,317,565.66 | 405,588,875.04 | 287,108,082.96 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,116,427,033.08 | 1,072,265,596.55 | 1,082,399,705.85 | 954,058,745.47 |
| 流动负债: | | | | |
| 短期借款 | 74,942,925.06 | 50,129,622.69 | 176,194,024.21 | 162,729,024.76 |
| 应付票据及应付账款 | 18,057,407.45 | 26,765,308.37 | 19,971,715.34 | 3,906,961.82 |
| 其中：应付票据 | - | 2,399,998 | 2,399,998 | - |
| 应付账款 | 18,057,407.45 | 24,365,310.37 | 17,571,717.34 | 3,906,961.82 |
| 合同负债 | 3,248,667.35 | 5,082,944.81 | 14,153,895.85 | 2,491,271.56 |
| 应付职工薪酬 | 3,032,771.49 | 5,687,463.95 | 3,212,876.56 | 2,358,686.83 |
| 应交税费 | 2,866,037.94 | 5,332,261.7 | 3,899,138.4 | 5,093,948.23 |
| 其他应付款合计 | 11,533,361.1 | 21,876,159.62 | 34,600,227.78 | 1,551,846.37 |
| 一年内到期的非流动负债 | 11,603,336.89 | 11,603,336.89 | 285,394.29 | 288,023.47 |
| 其他流动负债 | 422,326.76 | 2,702,587.43 | 1,840,006.46 | 323,166.35 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 125,706,834.04 | 129,179,685.46 | 254,157,278.89 | 178,742,929.39 |
| 非流动负债: | | | | |
| 长期借款 | 188,216,919.88 | 118,080,017.1 | - | - |
| 租赁负债 | 313,761.41 | 306,000 | 331,927.41 | 607,057.23 |
| 递延收益 | 2,110,553.25 | 2,121,303.24 | 2,132,053.23 | - |
| 递延所得税负债 | 897,075.61 | 901,532.96 | 43,992.27 | 58,656.36 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 191,538,310.15 | 121,408,853.3 | 2,507,972.91 | 665,713.59 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 317,245,144.19 | 250,588,538.76 | 256,665,251.8 | 179,408,642.98 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 80,000,000 | 80,000,000 | 80,000,000 | 80,000,000 |
| 资本公积 | 509,115,069.23 | 509,217,874.62 | 509,501,460.23 | 509,501,460.23 |
| 减:库存股 | 19,999,010.49 | - | - | - |
| 其他综合收益 | 795,406.09 | 676,095.18 | 6,605,557.86 | 6,605,557.86 |
| 盈余公积 | 20,260,274.89 | 20,260,274.89 | 16,090,946.49 | 16,090,946.49 |
| 未分配利润 | 159,373,371.17 | 161,910,647.31 | 166,466,708.95 | 161,522,255.81 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 749,545,110.89 | 772,064,892 | 778,664,673.53 | 773,720,220.39 |
| 少数股东权益 | 49,636,778 | 49,612,165.79 | 47,069,780.52 | 929,882.1 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 799,181,888.89 | 821,677,057.79 | 825,734,454.05 | 774,650,102.49 |
| 负债和股东权益合计 | 1,116,427,033.08 | 1,072,265,596.55 | 1,082,399,705.85 | 954,058,745.47 |
| 公告日期 | 2024-04-25 | 2024-04-18 | 2023-10-27 | 2023-08-25 |
| 审计意见(境内) | | 标准无保留意见 | | |